NCT01883596

Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.

Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in a Pediatric Intensive Care Unit.

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: Sinaloa Pediatric Hospital · Academic / Other
• Sex: All
• Age: 1 Month – 18 Years
• Healthy volunteers: Not accepted

Summary

To determine the efficacy of prophylaxis with 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

Detailed description

Randomised controlled trial to determine the efficacy of 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

Conditions

• Mechanical Ventilation for More Than 48 Hours.

Interventions

Type	Name	Description
DRUG	0.12% chlorhexidine solution	Bexident® (0.12% chlorhexidine solution)
DRUG	Placebo	7.4% alcohol, glycerine, normal saline solution, applied topically, every 8 hrs.

Timeline

• Start date: 2012-10-01
• Primary completion: 2016-10-01
• Completion: 2016-12-01
• First posted: 2013-06-21
• Last updated: 2015-12-08

Locations

1 site across 1 country: Mexico